Combining results of microarray experiments: A rank aggregation approach

Statistical Applications in Genetics and Molecular Biology

Volumn 5, Issue 1, 2006, Pages

  DeConde, Robert P ^a   Hawley, Sarah ^a   Falcon, Seth ^a   Clegg, Nigel ^a   Knudsen, Beatrice ^a   Etzioni, Ruth ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Markov chains; Meta analysis; Microarrays; Order statistic models; Rank aggregation

Indexed keywords

ALGORITHM; ARTICLE; COMPUTER SYSTEM; DNA MICROARRAY; GENE EXPRESSION; MATHEMATICAL COMPUTING; MICROARRAY ANALYSIS; PROBABILITY; SCIENTIFIC LITERATURE; STATISTICAL ANALYSIS; STATISTICAL MODEL; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; HUMAN; INFORMATION PROCESSING; MALE; META ANALYSIS; METABOLISM; METHODOLOGY; PROSTATE TUMOR; SIGNAL PROCESSING; STATISTICS; TISSUE MICROARRAY;

ALGORITHMS; COMPUTER SIMULATION; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MARKOV CHAINS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TISSUE ARRAY ANALYSIS;

EID: 85047234321     PISSN: 15446115     EISSN: 15446115     Source Type: Journal    
DOI: 10.2202/1544-6115.1204     Document Type: Article

References (33)

1. Bradley, R.A. and Terry, M.A. (1952) Rank analysis of incomplete block designs. I. Biometrika, 39:324-345.
2. Benjamini Y., Hochberg Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B, 57(1):289-300.
3. De Smet, Y., Sprinagael, J., Kunsch, P. (2002) Towards statistical multicritera decision modeling: A first approach. Journal of Multi-Criteria Decision Analyis, 11(6):305-313.
4. Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K.J., Rubin, M.S. and Chinnaiyan,A.M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature, 412(6839):822-826.
5. Dong, Y., Zhang, H., Gao, A.C., Marshall, J.R., Ip, C. (2005) Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers. Mol Cancer Ther 4(7):1047-1055.
6. Dwork, C., Kumar, R., Naor, M. and Sivakumar, D. (2001) Rank aggregation methods for the web. http://www10.org/cdrom/papers/577/
7. Fagin, R., Kumar, R. and Sivakumar, D. (2003) Comparing top-k lists. SIAM J. Discrete Math., 17(1):134-160.
8. Fligner, M.A. and Verducci,J.S. (1988) Multistage ranking models. J Am Stat Assoc., 83(403):892-901.
9. Ignatiuk, A., Quickfall, J.P., Hawrysh, A.D., Camberlain, M.D., Anderson, D.H. (2006) The smaller isoforms of ankyrin 3 bind to the p85 subunit of phosphatidylinositol 3′-kinase and enhance platelet-derived growth factor receptor down-regulation. J Biol Chem 281(9):5956-5964.
10. Ivanova, A., Liao, S.Y., Lerman, M.I., Ivanov, S., Stanbridge, F.J. (2005) STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiaion marker. J Med Genet 42(7):556-576.
11. Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R., Matusik, R., Vasioukhin, V. (2004) Hepsin promotes prostate cancer and metastasis. Cancer Cell. 6(2):185-195
12. Kooperberg, C., Aragaki, A., Strand, A.D., Olson, J.M. (2005) Significance testing for small microarray experiments. Statistics in Medicine 24(15):2281-2298.
13. Kuefer, R., Varambally, S., Zhou, M., Lucas, P.C., Loeffler, M., Wolter, H., Mattfeldt, T., Hautmann, R.E., Gschwend, J.E., Barrette, T.R., Dunn, R.L., Chinnaiyan, A.M., Rubin, M.A. (2002) alpha-Methylacyl-CoA racemase: expression levels of this novel cancer biomarker depend on tumor differentiation. Am J Pathol 161(3):841-848.
14. Luo, J., Duggan, D.J., Chen, Y., Sauvageot, J., Ewing, .M., Bittner, M.L., Trent, J.M. and Isaacs, W.B. (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res., 61(12):4683-4688.
15. Marden, J.I. (1995) Analyzing and modeling rank data. Chapman and Hall, London.
16. Maydeu-Olivares, A. (1999) Thursonian modeling of ranking data via mean and covariance structure analysis. Psychometrika, 64(3):325-340.
17. McCarroll, S.A., Murphy, C.T., Zou, S., Pletcher, S.D., Chin, C.S., Kenyon, C., Bargmann, C. and Li, H. (2004) Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nature Genetics, 36(2):197-204.
18. Parmigiani, G., Garrett-Mayer, E.S., Anbazhagan, R. and Garielson, E. (2004) A cross-study comparison of gene expression studies for the molecular classification of lung cancer. Clinical Cancer Research, 10(9):2922-2927.
19. Pizer, E.S., Pflug, B.R., Bova, G.S., Han, W.F., Udan, M.S., Nelson, J.B. (2001) Increased fatty acid synthase as a therapeutic target in adrogen-independent prostate cancer progression. Prostate 47(2):102-110.
20. Plackett, R.L. (1975) The analysis of permutations. Applied Statistics, 24:193-202.
21. Rhodes, D.R., Barrette, T.R., Rubin, M.A., Ghosh,D. and Chinnaiyan,A.M. (2002) Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res., 62(15):4427-4433.
22. Rhodes, D.R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A. and Chinnaiyan, A.M. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA., 101(25):9309-9314.
23. Singh, D., Febbo, P.G., Ross, K., Jackson, D.G., Manola, J., Ladd, C., Tamayo, P., Renshaw, A.A., D'Amico, A.V., Richie, J.P., Lander, E.S., Loda, M., Kantoff, P.W., Golub, T.R., Sellers, W.R. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1(2):203-209.
24. Smith, B.B. (1950) Discussion of professor Ross's paper. J R Stat Soc Ser B, 12:53-56.
25. Thurstone, L.L. (1927) A law of comparative judgement. Phycological Rev., 79:281-299.
26. Thurstone, L.L. (1931) Rank order as a psychological method. J Exp. Psychol., 14:187-201.
27. True, L., Coleman, I., Hawley, S., Huang, A., Gifford, D., Coleman, R., Beer, T., Gelman, E., Datta, M., Mostaghel, E., Knudsen, B., Lange, P., Vessella, R., Lin, D., Hood, L., Nelson, P. (2006) A Molecular Correlate to the Gleason Grading System for Prostate Adenocarcinoma. Proc Natl Acad Sci U S A., forthcoming.
28. Tusher, V.G., Tibshirani, R., Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A., 98(9):5116-21.
29. Varambally S., Yu J., Laxman B., Rhodes D.R., Mehra R., Tomlins S.A., Shah R.B., Chandran U., Monzon F.A., Becich M.J., Wei J.T., Pienta K.J., Ghosh D., Rubin M.A., Chinnaiyan A.M. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 8(5):393-406.
30. Wang, J., Coombes, K.R., Highsmith,W.E., Keating, M.J and Abruzzo, L.V. (2004) Differences in gene expression between B-cell chronic lymphcytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics, 20(17):3166-3178.
31. Welsh, J.B., Sapinoso, L.M., Su, A.I., Kern, S.G., Wang-Rodriguez, J., Moskaluk, C.A., Frierson, H.F.Jr. and Hampton,G.M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61(16):5974-5978.
32. Xu L., Tan A.C., Naiman D.Q., Geman D., and Winslow R.L. (2005) Robust cancer marker genes emerge from direct integration of inter-study microarray data. Bioinformatics, 21(20):3905-3911.
33. Yuen, T., Wurmbach, E., Pfeffer, R.L., Ebersole, B.J. and Sealfon, S.C. (2002) Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res., 30:e48.